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Activity of two hyaluronan preparations on primary human oral 
fibroblasts






















Material and Methods:	Metabolic,	 proliferative	 and	migratory	 abilities	 of	 primary	
human	palatal	and	gingival	 fibroblasts	were	examined	upon	HA	treatment.	To	un-























©	2018	The	Authors.	Journal of Periodontal Research	Published	by	John	Wiley	&	Sons	Ltd.




and	 tissue	hydration.	HA	 is	present	 in	various	body	 fluids	 such	as	
synovial	 fluid,	 serum,	 saliva,	 and	gingival	 crevicular	 fluid1-3	 as	well	
as	 in	 mineralized	 and	 non-	mineralized	 tissues,	 including	 the	 peri-
odontium.4	Higher	amounts	of	HA	are	detected	in	gingiva	and	peri-






processes	 during	 tissue	 repair	 and	 regeneration,	 detailed	 mecha-
nisms	of	action	especially	in	oral	soft	tissue	wound	healing	following	
periodontal	regenerative	procedures	remain	largely	uncovered.
During	 wound	 healing,	 HA	 exhibits	 differential	 effects	 based	
on	its	molecular	weight	(MW).9	 In	early	stages,	there	is	a	sharp	in-
crease	 in	 high	MW	 (>1000	kDa)	HA,	which	has	 the	 ability	 to	bind	







(TNF-	α),	 interleukin-	1β	 (IL-	1β)	 and	 IL-	812	 as	well	 as	 angiogenesis.13 
In	periodontal	wound	healing	 in	particular,	HA	has	been	shown	to	
induce	 production	 of	 pro-	inflammatory	 cytokines	 by	 fibroblasts,	
keratinocytes,	cementoblasts,	and	osteoblasts,	which	promotes	the	





derived	 growth	 factor	 (PDGF),	 fibroblast	 growth	 factor-	2	 (FGF-	2),	
and	epidermal	growth	factor	(EGF).15	MMPs	degrade	ECM	compo-
nents	 and	 elicit	 a	 pro-	inflammatory	 response,	 thus	 promoting	 cell	






is	 a	 potent	 stimulator	 of	 epithelialization,	 angiogenesis,	 fibroblast	
proliferation,	and	survival.20
A	number	of	studies	describe	the	use	of	exogenous	HA	in	non-	








two	 commercially	 available	 HA	 preparations	 of	 non-	animal	 origin	
planned	 to	 be	 used	 in	 reconstructive	 periodontal	 surgery.	 The	 in-
fluence	of	the	two	HA	preparations	on	the	proliferative	and	migra-
tory	 abilities	 of	 primary	 human	palatal	 and	 gingival	 fibroblasts,	 as	






2  | MATERIAL AND METHODS
2.1 | Cell culture and HA preparations
Primary	 human	 palatal	 (HPF)	 and	 gingival	 (HGF)	 fibroblasts	 were	
obtained	 from	 three	 donors	 each	 using	 tissue	 explant	 technique.	
Tissue	samples	harvested	from	either	subepithelial	palatal	connec-
tive	tissue	grafts	(for	obtaining	HPFs)	or	subepithelial	buccal	gingival	
tissues	 (for	 obtaining	HGFs)	were	 retrieved	 from	 systemically	 and	
periodontally	 healthy	 anonymous	 individuals	 below	30	years,	who	
had	 undergone	 periodontal	 surgery	 (eg,	 recession	 coverage	 using	
palatal	 subepithelial	 connective	 tissue	 grafts	 or	 crown	 lengthen-
ing)	 following	signed	 informed	consent	and	approval	by	the	Ethics	
Committee	of	the	University	of	Bern.	Each	donor	tissue	sample	was	
minced	 into	 1-	mm	 tissue	 explant	 pieces,	 which	 were	 then	 pipet-
ted	 into	a	25-	cm3	 tissue	culture	 flask	and	cultivated	 in	Dulbecco’s	
modified	 Eagle’s	 medium	 (DMEM;	 Invitrogen,	 Basel,	 Switzerland)	
supplemented	 with	 10%	 fetal	 calf	 serum	 (FCS;	 Invitrogen).	 Thus,	
each	of	the	HPF	and	HGF	strains	originating	from	individual	donors	
represents	a	mixture	of	 fibroblasts	 that	grew	of	multiple	explants.	
Fibroblasts	 that	had	not	undergone	more	 than	 five	passages	were	
starved	in	0.3%	FCS/DMEM	before	treatment	with	HA.
Hyaluronan	 was	 kindly	 provided	 by	 Regedent	 AG	 (Zurich,	
Switzerland)	in	two	formulations:	(a)	HA1	(hyaDENT),	a	native	non-	
cross-	linked	HA	with	MW	of	2500	kDa;	and	(b)	HA2	(hyaDENT	BG),	
a	 formulation	 containing	 complexes	 of	 butanediol	 diglycidyl	 ether	
(BDDE)	cross-	linked	1000	kDa-	HA	monomers	and	 the	above	non-	









DMEM	 for	 18	hour	 and	 then	 treated	with	HA	 applied	 on	 the	 top	
for	30	minutes.	For	both	types	of	analyses,	HA	was	used	at	a	final	
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concentration	of	4	mg/mL	 in	0.3%FCS/DMEM.	This	 concentration	




surgical	 procedure.	 In	 some	cases,	 cells	were	 treated	with	 recom-
binant	 IL-	1α,	 IL-	1β	 or	 TNF-	α	 protein	 (PeproTech,	 London,	 UK)	 for	
48	hours	before	RNA	extraction.
2.2 | Cell viability assay
Cell	 viability	 was	 assessed	 by	 the	 CellTiter-	Blue	 viability	 assay	
(Promega,	Madison,	WI,	 USA).	 After	 24	hour	 of	 starvation,	 cells	
were	 plated	 in	 triplicate	 at	 5	×	103	 cells/well	 on	 96-	well	 plates	
coated	with	HA	at	 the	 indicated	 concentrations	 (in	 the	 range	of	
0	 and	 4	mg/mL)	 prepared	 in	 0.3%FCS/DMEM.	 Two	 hours	 post-	
seeding,	 CellTiter-	Blue®	 Reagent	 (20	μL/well)	 was	 added	 to	 the	
cells	 for	 4	hour	 before	 recording	 fluorescence	 using	 a	 luminom-
eter	Infinite®	200	(Tecan,	Männedorf,	Switzerland).	Experimental	
values	 were	 normalized	 to	 the	 values	 of	 untreated	 cells	 (100%	




Proliferation	 rates	 of	 HA-	treated	 HPF	 or	 HGF	 cells	 were	 deter-
mined	 using	 a	 5-	bromo-	20-	deoxyuridine	 (BrdU)	 incorporation	






manufacturer’s	 instructions.	 Experimental	 values	were	 normalized	
to	the	values	of	untreated	cells	at	the	time	point	0.	Data	represent	
means	±	SD	 from	 three	 independent	 experiments	 performed	with	
three	different	cell	donors,	each	in	triplicates.
2.4 | Cell migration assay
Cell	migration	was	 assayed	 using	 transwell	 polycarbonate	mem-
brane	 inserts	 (Corning,	 Amsterdam,	 The	 Netherlands)	 as	 de-
scribed.27	After	24	hour	of	starvation,	5	×	104	cells	were	plated	in	
the	top	insert	chamber	in	serum-	free	DMEM.	The	lower	chamber	
was	coated	with	HA	at	a	 final	 concentration	of	4	mg/mL	 in	10%	
FCS/DMEM.	 Cells	 were	 allowed	 to	 migrate	 across	 the	 filter	 for	
18	hour	at	37°C	before	fixation	and	crystal	violet	staining.	Images	
of	 duplicate	 inserts	were	 acquired	on	 an	Olympus	BX-	51	micro-
scope.	Migration	was	 quantified	 by	 using	 the	 Fiji	 distribution	 of	
ImageJ	 as	 published	 before.27	 Data	 represent	 means	±	SD	 from	
three	 independent	 experiments	 performed	 with	 three	 different	
cell	donors,	each	in	triplicates.
2.5 | qRT- PCR














pared	 by	 lysis	 in	RIPA	buffer	 as	 described.30	 Lysates	were	 run	 on	
10%	SDS-	PAGE,	and	transferred	to	Amersham™	Protran® membrane 
(Sigma,	Basel,	Switzerland).	Proteins	of	interest	were	visualized	using	
anti-	phospho-	Akt,	 anti-	Akt,	 anti-	phospho-	Erk1/2,	 anti-	Erk,	 anti-	
phospho-	p38,	anti-	p38	(all	from	Cell	Signaling	Technology,	Danvers,	
MA,	USA),	and	anti-	vinculin	(Sigma)	antibodies	followed	by	horserad-
ish	 peroxidase-	conjugated	 secondary	 antibodies	 (MP	 Biomedicals,	
Santa	Ana,	CA,	USA)	for	detection	with	the	SuperSignal™	West	Dura	
Substrate	 (ThermoFisher	 Scientific,	 Zug,	 Switzerland).	 Phospho-	
Akt,	 phospho-	Erk1/2	 or	 phospho-	p38	 protein	 expression	 relative	
to	 the	 respective	 total	 protein	 control	 was	 quantified	 by	 densi-
tometry	 using	 ImageQuant	 (Molecular	 Dynamics,	 Groningen,	 The	





hoc	 test	 using	GraphPad	 InStat	 Software,	 version	 3.05.	 Values	 of	
P	<	0.05	were	considered	statistically	significant.
3  | RESULTS
3.1 | The two HA preparations exert no negative 





ogy	of	 untreated	 cells	 seeded	on	non-	coated	 cell	 culture	 plastic	
(Figure	S1).	 In	contrast,	 coating	with	HA2	resulted	 in	 the	 forma-
tion	of	HA	meshes,	most	 likely	due	to	HA2	being	cross-	linked	to	
BDDE.	 Thus,	 cells	 appeared	 to	 adhere	 solely	 on	 the	 cell	 culture	
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We	 first	 compared	 the	effects	of	 the	 two	HA	preparations	on	
HPF	and	HGF	cell	viability.	Relative	 to	control	 cells	 (0	mg/mL	HA;	
100%	cell	viability),	 fibroblasts	exposed	to	HA1	or	HA2	at	various	
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3.2 | The two HA preparations strongly increase the 
proliferative and migratory abilities of primary 




HA2	 showed	 a	 significant	 increase	 in	 BrdU	 uptake	 into	 newly	
synthesized	 DNA	 until	 they	 reached	 confluence	 72	hours	 later	
(Figure	1B,	 left	 panel).	 In	 contrast,	 HGF	 cells	 exposed	 to	 each	
of	 the	 two	HAs	 behaved	 like	 control	 cells	 in	 the	 first	 24	hours	
(Figure	1B,	 right	 panel).	 Thereafter,	 they	 showed	 a	 significant	
increase	in	BrdU	uptake	until	they	reached	confluence	48	hours	
later.	Compared	to	HA1,	the	pro-	proliferative	effect	of	HA2	ap-
peared	 to	be	slightly	more	pronounced	 in	both	cell	 types,	but	a	
significant	difference	(P	<	0.01)	in	the	activity	of	the	two	HAs	was	
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Next,	 we	 examined	 the	 migratory	 capacity	 of	 oral	 fibroblasts	
toward	HA	using	a	transwell	assay.	Similarly	to	the	effect	on	cellu-






3.3 | The two HA preparations trigger expression of 
COL3A1 and TGFB3 genes characterizing scarless 
wound healing
Invasion	and	proliferation	of	fibroblasts	at	the	defect	site	precedes	
collagen	 deposition.	 Thus,	 we	 next	 studied	 the	 effect	 of	 the	 HA	
preparations	 on	 the	 expression	 of	 type	 I	 and	 type	 III	 collagens	 in	
the	primary	oral	fibroblasts	(Figure	2A	and	B).	Accumulation	of	type	
I	collagen	 is	enhanced	 in	scars	and	fibrosis,	whereas	type	 III	colla-
gen	is	abundant	during	fetal	development	and	scarless	fetal	wound	
healing.31	 Interestingly,	compared	to	untreated	control	cells,	either	
HA	 preparation	 upregulated	 the	 expression	 levels	 of	 COL3A1	 in	
both	HPFs	and	HGFs	at	24	hour	 (Figure	2B),	whereas	no	effect	on	
COL1A1	mRNA	levels	was	detected	(Figure	2A).
We	 further	 determined	 the	 influence	 of	 the	HA	preparations	
on	 the	 expression	 of	 TGFB1	 and	 TGFB3	 (Figure	2C	 and	 D),	 two	
TGF-	β	 isoforms	 that	play	 critical	 roles	 in	wound	healing	by	mod-
ulating	 ECM	 formation.	 Whereas	 TGF-	β1	 is	 generally	 known	 as	
pro-	fibrotic,	 TGF-	β3	 is	 the	 isoform	 that	 predominates	 in	 scarless	
fetal	wound	healing.32	Interestingly,	both	HAs	caused	a	significant	
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(Figure	2D),	 whereas	 the	 expression	 of	 TGFB1	 was	 unchanged	
(Figure	2C).	Furthermore,	 in	both	cell	 types,	HA1	appeared	 to	be	
more	potent	(by	2-	fold,	P	<	0.001)	than	HA2	in	inducing	TGFB3	ex-
pression	(Figure	2D).
These	 results	 indicated	 that	both	HAs	 favor	 the	expression	of	
genes	characteristic	of	scarless	vs	pro-	fibrotic	wound	healing.
3.4 | HA induces expression of genes encoding 
growth factors and cytokines involved in wound 
healing in primary HPF and HGF cells
Growth	factors	such	as	PDGFB,	FGF-	2	and	EGF	stimulate	the	pro-














both	HAs	 caused	 a	 significant	 upregulation	 of	mRNA	 levels	 for	
each	cytokine	in	both	HPFs	and	HGFs.	A	slightly	but	significantly	
higher	 induction	of	 IL1A	expression	was	 triggered	by	HA1	com-




types	was	possible	based	on	 (a)	 identical	basal	expression	 levels	
for	 each	 of	 the	 three	mRNAs	 encoding	 pro-	inflammatory	 cyto-
kines	 in	 control	 HPFs	 and	 HGFs	 (Ctctrl	=	33	 for	 IL1A;	 Ctctrl	= 30 
for	IL1B,	and	Ctctrl	=	31	for	TNF)	and	(b)	identical	endogenous	HA	
expression	 levels	 in	 culture	 supernatants	 of	 the	 two	 cell	 types	
(Figure	S2).






3.5 | HA induces cell type- specific differences in the 
expression of MMP2 and MMP3 genes
During	oral	wound	healing,	the	granulation	tissue	ECM	is	continu-
ously	 remodeled	 by	 MMPs,	 most	 notably	 collagenases	 MMP-	1	
and	 8,	 major	 gelatinase	 MMP-	2,	 and	 stromelysin-	1	 (MMP-	3).35 
qRT-	PCR	analyses	revealed	that	treatment	of	both	cell	types	with	




higher	 expression	 of	MMP8	 than	HA2	 in	HPFs	 only	 (Figure	4B,	
left	 panel).	 Interestingly,	 we	 observed	 a	 significant	 induction	
of	 MMP2	 mRNA	 levels	 in	 HA-	treated	 HPF	 but	 not	 HGF	 cells	
(Figure	4C),	despite	the	facts	that	 (a)	MMP2	is	constitutively	ex-
pressed	by	mucosal	 fibroblasts36	 and	 (b)	 basal	 expression	 levels	







3.6 | Pro- inflammatory cytokines exhibit a 
stimulatory and dose- dependent effect on MMP2 and 













independently	 influence	 MMP1	 and	 MMP8	 gene	 expression	 (cf.	
Figure	4A,	B),	the	effect	of	HA	on	MMP2	and	MMP3	expression	in	
HPF	and	HGF	cells	appears	to	occur	indirectly	and	reflects	the	HA-	
induced	 expression	 of	 pro-	inflammatory	 cytokines	 (cf.	 Figures	4C,	
D	and	3D-	F).
3.7 | The two HA preparations significantly enhance 





We	 focused	 on	 the	 activation	 of	 PI3-	kinase/Akt,	 Erk1/2,	 and	 p38,	
because	HA	has	been	reported	to	stimulate	these	pathways	in	other	
systems.9	 Compared	 to	 the	 basal	 levels	 of	 phospho-	Akt,	 phospho-	
Erk1/2,	and	phospho-	p38	detected	 in	control	cells,	phosphorylation	
of	each	of	the	three	kinases	significantly	increased	in	both	HPFs	and	
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4  | DISCUSSION
Palatal	and	gingival	fibroblasts	play	an	important	role	in	oral	wound	
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including	proliferation,	migration,	and	wound	healing-	related	gene	
expression.	All	these	processes	affect	soft	tissue	wound	healing/
regeneration	 following	 reconstructive	 periodontal	 surgery.	 Our	
data	demonstrate	 that	both	 formulations	of	HA	 (a)	are	 fully	bio-
compatible	and	exert	no	negative	effects	on	the	viability	of	HPFs	





ing	 process;	 (e)	 induce	 pro-	inflammatory	 cytokine	 gene	 expres-






fibroblasts.	 Understanding	 the	mechanisms	whereby	 these	 HAs	
function	may	reveal	how	to	 intervene	 in	 the	dynamic	process	of	
oral	soft	tissue	regeneration	with	the	aim	to	improve	it.
The	 investigated	 HA	 preparations	 appear	 close	 to	 the	 phys-
iological	 HA	 that	 is	 found	 in	 many	 biological	 fluids	 and	 solid	 tis-
sues	and	 is	 reported	 to	possess	an	average	MW	of	approximately	
1000-	6000	kDa.37	 Little	 if	 any	 HA	 below	 1000	kDa	 is	 found	 in	
healthy	 solid	 tissues.37	 On	 the	 other	 hand,	 human	 amniotic	 fluid	







blasts,	 fibroblasts,	 and	periodontal	 ligament	 (PDL)	 cells	have	been	
reported	 previously	 with	 other	 HA	 formulations.40,41	 The	 cross-	
linking	 to	BDDE,	which	 characterizes	 one	of	 our	HA	 formulations	
(HA2),	 did	 not	 seem	 to	 negatively	 influence	 cell	 viability	 as	 also	
shown	by	others.42
The	 effect	 of	 HA	 on	 cell	 proliferation	 in	 vitro	 is	 known	 to	 be	
closely	 related	 to	 its	MW	and	 concentration.22	 Low	MW	HA	was	
reported	to	increase	cell	proliferation	in	studies	with	rat	and	mouse	

































of	HA	 on	 oral	 fibroblasts	 that	we	 have	 detected.	 Consistent	with	




encoding	 pro-	proliferative	 and	 pro-	migratory	 growth	 factors	 such	
as	PDGFB,	FGF-	2,	and	EGF.	Furthermore,	once	upregulated	at	the	







mediated	motility	 expressed	 protein),	 or	 LYVE-	1	 (lymphatic	 vessel	







growth	 factor	 receptor	 (EGFR)	 are	 essential	 for	 modulating	 HA-	
dependent	fibroblast	proliferation.54
The	 high	 abundance	 of	 HA	 in	 amniotic	 fluid	 and	 embryonic	
tissues	and	 its	 involvement	 in	a	mechanism	 that	 supports	 scarless	
repair	 in	 the	 fetus	are	well	documented.55	Here,	we	report	an	up-






Exogenous	 high	 MW-	HA	 has	 been	 shown	 to	 be	 anti-	
inflammatory,	eg,	in	a	T	cell-	mediated	liver	injury	model	in	mice56 
or	 in	 fibroblast-	like	 synoviocytes	 in	 a	 human	 osteoarthritis	
model.57	 On	 contrary,	 we	 observed	 an	 increased	 expression	 of	
pro-	inflammatory	cytokines	in	oral	fibroblasts	treated	with	each	of	
the	two	high	MW-	HAs.	Others	have	also	shown	that	high	MW-	HA	
stimulates	production	of	 IL-	1β,	TNF-	α,	and	 IL-	8	 in	human	uterine	
fibroblasts.12	These	contradictions	might	be	related	to	the	specific	
HA	 formulations	 as	 well	 as	 the	 cellular	 context	 used.	 However,	
as	 an	 inflammatory	 reaction	 is	 generally	 indispensable	 for	 the	
kick-	off	of	wound	 repair,	 the	pro-	inflammatory	effect	of	 the	HA	
preparations	 tested	 in	 the	 current	 study	might	 appear	 clinically	




















MMPs	acting	 for	 a	 long	 time	on	 the	healing	 tissue,	 are	deleteri-
ous	for	the	wound	healing	process.	 In	this	respect,	the	observed	
indirect	effect	on	the	expression	of	MMP2	and	MMP3,	as	well	as	
the	moderate	 induction	of	 pro-	inflammatory	 cytokines	 in	HGFs,	



















fibroblasts,	 two	cell	 types	 involved	 in	soft	 tissue	 regeneration	 fol-
lowing	periodontal	reconstructive	therapies	that	utilize	palatal	con-
nective	tissue	or	free	gingival	grafts.	The	observed	pro-	proliferative,	
pro-	migratory	 and	 pro-	wound	 healing	 properties	 of	 the	 two	 HAs	
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